CN101505778A - 含有来自金合欢属树皮的物质的降血糖组合物 - Google Patents
含有来自金合欢属树皮的物质的降血糖组合物 Download PDFInfo
- Publication number
- CN101505778A CN101505778A CNA2006800555916A CN200680055591A CN101505778A CN 101505778 A CN101505778 A CN 101505778A CN A2006800555916 A CNA2006800555916 A CN A2006800555916A CN 200680055591 A CN200680055591 A CN 200680055591A CN 101505778 A CN101505778 A CN 101505778A
- Authority
- CN
- China
- Prior art keywords
- acacia
- bark
- willd
- compositions
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000220479 Acacia Species 0.000 title claims abstract description 53
- 235000010643 Leucaena leucocephala Nutrition 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 23
- 239000000284 extract Substances 0.000 claims description 50
- 244000020998 Acacia farnesiana Species 0.000 claims description 47
- 235000003074 Acacia farnesiana Nutrition 0.000 claims description 47
- 239000000463 material Substances 0.000 claims description 18
- 235000013305 food Nutrition 0.000 claims description 17
- 241001465754 Metazoa Species 0.000 claims description 15
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 15
- 235000013824 polyphenols Nutrition 0.000 claims description 15
- 241001199697 Acacia dealbata Species 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 10
- 241000993444 Acacia mearnsii Species 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 235000018553 tannin Nutrition 0.000 claims description 6
- 229920001864 tannin Polymers 0.000 claims description 6
- 239000001648 tannin Substances 0.000 claims description 6
- 241000278701 Acacia mangium Species 0.000 claims description 5
- 235000017631 Acacia mangium Nutrition 0.000 claims description 5
- 230000037396 body weight Effects 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 4
- 244000236161 Acacia decurrens Species 0.000 claims description 3
- 240000001335 Acacia pycnantha Species 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- -1 flavanol compound Chemical class 0.000 claims description 3
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 claims description 2
- 235000011987 flavanols Nutrition 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 230000002035 prolonged effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 239000000843 powder Substances 0.000 description 26
- 238000012360 testing method Methods 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 206010012601 diabetes mellitus Diseases 0.000 description 20
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 239000008103 glucose Substances 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 201000001421 hyperglycemia Diseases 0.000 description 14
- 235000011468 Albizia julibrissin Nutrition 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 239000003826 tablet Substances 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- 230000002265 prevention Effects 0.000 description 9
- 238000002156 mixing Methods 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 210000000051 wattle Anatomy 0.000 description 6
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000007670 refining Methods 0.000 description 5
- 101150046735 LEPR gene Proteins 0.000 description 4
- 101150063827 LEPROT gene Proteins 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 210000003038 endothelium Anatomy 0.000 description 4
- 239000002031 ethanolic fraction Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 2
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 2
- 206010012665 Diabetic gangrene Diseases 0.000 description 2
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 208000033679 diabetic kidney disease Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- VFZYLYJWCROVLO-UHFFFAOYSA-N ent-Fisetidinol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 VFZYLYJWCROVLO-UHFFFAOYSA-N 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 235000007219 (+)-catechin Nutrition 0.000 description 1
- 229930013915 (+)-catechin Natural products 0.000 description 1
- 244000301344 Acacia baileyana Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000143476 Bidens Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010070070 Hypoinsulinaemia Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- GMPPKSLKMRADRM-UHFFFAOYSA-N Robidanol Natural products OC1CC2=CC=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 GMPPKSLKMRADRM-UHFFFAOYSA-N 0.000 description 1
- 241001260874 Sargassum horneri Species 0.000 description 1
- 241001355994 Sargassum phyllocystum Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000035860 hypoinsulinemia Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- GMPPKSLKMRADRM-SWLSCSKDSA-N robinetinidol Chemical compound C1([C@H]2OC3=CC(O)=CC=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 GMPPKSLKMRADRM-SWLSCSKDSA-N 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
给予组 | 动物数 | 胰岛素(ng/ml) | 糖化血红蛋白(g/dL) |
对照组 | 7 | 2.6±1.3 | 1.0±0.3 |
金合欢No.1热水提取物0.5%给予组 | 7 | 1.5±0.4(-42.3%) | 1.1±0.1(-10.0%) |
金合欢No.1热水提取物1.5%给予组 | 7 | 3.4±2.0(30.8%) | 1.0±0.2(0.0%) |
金合欢No.1热水提取物5.0%给予组 | 7 | 4.0±0.9(53.8%) | 0.5±0.1**(50.0%) |
Claims (13)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2006/315863 WO2008018138A1 (fr) | 2006-08-10 | 2006-08-10 | Composition hypoglycémique contenant un composant issu de l'écorce d'un arbre appartenant au genre acacia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101505778A true CN101505778A (zh) | 2009-08-12 |
CN101505778B CN101505778B (zh) | 2012-09-05 |
Family
ID=39032683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800555916A Active CN101505778B (zh) | 2006-08-10 | 2006-08-10 | 含有来自金合欢属树皮的物质的降血糖组合物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8128969B2 (zh) |
EP (1) | EP2052728B1 (zh) |
KR (1) | KR101398715B1 (zh) |
CN (1) | CN101505778B (zh) |
AU (1) | AU2006347121B2 (zh) |
BR (1) | BRPI0621960A2 (zh) |
WO (1) | WO2008018138A1 (zh) |
ZA (1) | ZA200901649B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010105923A (ja) * | 2008-10-28 | 2010-05-13 | Mimozax Co Ltd | アカシア属樹皮由来物を含有するPPARδ発現促進剤 |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6425726A (en) | 1987-04-24 | 1989-01-27 | Yuutoku Yakuhin Kogyo Kk | Agent for eliminating active oxygen free radical |
JPH03287507A (ja) | 1990-04-05 | 1991-12-18 | Iwata Kagaku Kogyo Kk | 汚損生物防除剤及び汚損防止塗料組成物 |
JP3232137B2 (ja) | 1992-08-21 | 2001-11-26 | 丸善製薬株式会社 | 活性酸素消去剤 |
FR2710533A1 (fr) | 1993-09-29 | 1995-04-07 | Nemet Pierre Alain | Nouvelles applications de l'extrait d'écorce de Tepesco Huite dans le domaine de la cosmétologie ou de la dermatologie. |
JP2747206B2 (ja) | 1993-11-12 | 1998-05-06 | 神協産業株式会社 | 高血糖改善用組成物 |
JP3290291B2 (ja) | 1994-05-02 | 2002-06-10 | ポーラ化成工業株式会社 | 活性酸素消去剤及びこれを含む組成物 |
JP3532999B2 (ja) | 1995-03-24 | 2004-05-31 | 株式会社ロッテ | 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤 |
JPH09291039A (ja) * | 1995-12-26 | 1997-11-11 | Suntory Ltd | プロシアニジンを有効成分とする抗肥満剤 |
ES2230573T3 (es) | 1995-12-26 | 2005-05-01 | Suntory Limited | Agente anti-obesidad cuyo principio activo es la procianidina. |
JPH1025238A (ja) | 1996-07-10 | 1998-01-27 | Mikimoto Pharmaceut Co Ltd | 皮膚外用剤 |
JP4831849B2 (ja) | 1997-04-23 | 2011-12-07 | 三省製薬株式会社 | 活性酸素消去剤およびその用途 |
JPH11180888A (ja) | 1997-12-24 | 1999-07-06 | Otsuka Pharmaceut Co Ltd | ヘリコバクター・ピロリ菌用の抗菌剤、感染予防剤および食品 |
JP2000044472A (ja) | 1998-07-30 | 2000-02-15 | Kikkoman Corp | 糖尿病性合併症の予防または治療薬剤 |
JP2000073056A (ja) | 1998-09-01 | 2000-03-07 | Sunstar Inc | 抗酸化性抽出物およびその製法 |
US20010024664A1 (en) | 1999-03-19 | 2001-09-27 | Obukowicz Mark G. | Selective COX-2 inhibition from edible plant extracts |
US6290993B1 (en) | 1999-07-23 | 2001-09-18 | E-L Management Corp. | Compositions containing mimosa phenolic compounds |
JP2001064172A (ja) | 1999-08-26 | 2001-03-13 | Kikkoman Corp | Apc遺伝子の変異に起因する疾患の予防・治療剤 |
JP2001098264A (ja) | 1999-09-30 | 2001-04-10 | Kobayashi Pharmaceut Co Ltd | 抗酸化剤及び活性酸素消去剤 |
JP2002010753A (ja) | 2000-04-24 | 2002-01-15 | Marukin Chuyu Co Ltd | オリーブ葉またはその抽出成分を含有するアミラーゼ阻害剤および高血糖者用食品 |
JP2002051736A (ja) | 2000-08-11 | 2002-02-19 | Mayekawa Mfg Co Ltd | ウインナ等燻製物の製造システム |
JP2002275076A (ja) | 2001-03-15 | 2002-09-25 | Toyo Shinyaku:Kk | 血糖上昇抑制剤および健康食品 |
NZ515523A (en) | 2001-11-15 | 2004-04-30 | Horticulture & Food Res Inst | Extraction of phenolic antioxidants |
US7108868B2 (en) | 2002-03-22 | 2006-09-19 | Unigen Pharmaceuticals, Inc. | Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
JP2003313138A (ja) | 2002-04-23 | 2003-11-06 | Kanzu Kenkyu Kaihatsu:Kk | 痒みを抑制するための薬剤または機能性食品、及びその効果の評価方法 |
WO2003092599A2 (en) | 2002-04-30 | 2003-11-13 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
JP2003342185A (ja) | 2002-05-25 | 2003-12-03 | Bhn Kk | リパーゼ活性阻害剤 |
CN1246011C (zh) | 2002-06-07 | 2006-03-22 | 云南白药集团天然药物研究院 | 藕节提取物在制备改善人体胰岛素抵抗和治疗或预防肥胖症的药物中的应用 |
JP2004024054A (ja) | 2002-06-21 | 2004-01-29 | Makoto Fujii | フコイダン系健康食品 |
JP2004051513A (ja) | 2002-07-18 | 2004-02-19 | Asahi Breweries Ltd | 抗腫瘍剤 |
JP2004075579A (ja) | 2002-08-13 | 2004-03-11 | Nippon Hypox Lab Inc | 外用鎮痒剤 |
JP4432069B2 (ja) | 2002-09-03 | 2010-03-17 | ビーエイチエヌ株式会社 | 肥満抑制剤 |
JP2004217559A (ja) | 2003-01-14 | 2004-08-05 | Maruhachi Muramatsu:Kk | 糖尿病態の予防・改善剤 |
WO2004075844A2 (en) * | 2003-02-26 | 2004-09-10 | Unigen Pharmaceuticals, Inc. | Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditions |
DE10308355A1 (de) | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
CN100381132C (zh) * | 2003-03-25 | 2008-04-16 | 邓家刚 | 降血糖中药制剂及其生产方法 |
JP2004300117A (ja) | 2003-04-01 | 2004-10-28 | Rasheru Seiyaku Kk | 化粧料組成物 |
JP4495406B2 (ja) | 2003-04-21 | 2010-07-07 | 株式会社武蔵野免疫研究所 | センダングサ属植物抽出物含有組成物 |
JP4730642B2 (ja) | 2003-05-28 | 2011-07-20 | 株式会社mimozax | 活性酸素消去剤及びその組成物 |
GB0317020D0 (en) | 2003-07-21 | 2003-08-27 | Sahajanand Biotech Private Ltd | Herbo-mineral formulation for refractory leukemias and lymphomas |
JP2005068081A (ja) | 2003-08-25 | 2005-03-17 | Asahi Breweries Ltd | 発癌予防剤 |
EP1660109A4 (en) | 2003-09-02 | 2009-04-08 | Unigen Pharmaceuticals Inc | FORMULATION OF A MIXTURE OF FREE B-RING FLAVONOIDS AND FLAVANES FOR USE IN THE PREVENTION AND TREATMENT OF COGNITIVE WEAKNESSING AND AGING MEMORY DISORDERS |
JP2005239559A (ja) | 2004-02-24 | 2005-09-08 | Nof Corp | ホスホリパーゼa2阻害剤 |
JP2006016330A (ja) | 2004-06-30 | 2006-01-19 | Suntory Ltd | 脂肪燃焼促進剤 |
JP5002127B2 (ja) * | 2005-02-28 | 2012-08-15 | 株式会社mimozax | アカシア属樹皮由来物を含有する血糖降下組成物 |
JP4823538B2 (ja) | 2005-02-28 | 2011-11-24 | 株式会社mimozax | アカシア属樹皮由来物を含有する抗肥満組成物 |
US20060204599A1 (en) | 2005-03-14 | 2006-09-14 | Wheat Jared R | Dietary supplement and method of using same |
AU2007261356A1 (en) * | 2006-06-20 | 2007-12-27 | Metaproteomics, Llc | Hexahydro-isoalpha acid based protein kinase modulation cancer treatment |
-
2006
- 2006-08-10 EP EP06782649.5A patent/EP2052728B1/en not_active Ceased
- 2006-08-10 US US12/376,902 patent/US8128969B2/en active Active
- 2006-08-10 WO PCT/JP2006/315863 patent/WO2008018138A1/ja active Application Filing
- 2006-08-10 AU AU2006347121A patent/AU2006347121B2/en not_active Ceased
- 2006-08-10 KR KR1020097004925A patent/KR101398715B1/ko active IP Right Grant
- 2006-08-10 BR BRPI0621960-8A patent/BRPI0621960A2/pt not_active Application Discontinuation
- 2006-08-10 CN CN2006800555916A patent/CN101505778B/zh active Active
-
2009
- 2009-03-09 ZA ZA2009/01649A patent/ZA200901649B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008018138A1 (fr) | 2008-02-14 |
BRPI0621960A2 (pt) | 2011-12-27 |
CN101505778B (zh) | 2012-09-05 |
EP2052728A4 (en) | 2012-03-21 |
ZA200901649B (en) | 2010-02-24 |
EP2052728A1 (en) | 2009-04-29 |
AU2006347121B2 (en) | 2013-06-06 |
US8128969B2 (en) | 2012-03-06 |
KR20090042838A (ko) | 2009-04-30 |
AU2006347121A1 (en) | 2008-02-14 |
EP2052728B1 (en) | 2018-06-13 |
US20100166899A1 (en) | 2010-07-01 |
KR101398715B1 (ko) | 2014-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102406860B (zh) | 预防和治疗糖尿病的组合物、其制备方法及应用 | |
CN101987169A (zh) | 采用复方生药提取物作为有效成分而用于防治糖尿病或者糖尿病并发症的组合物 | |
CN101505775B (zh) | 含有来自金合欢属树皮的物质的抗氧化组合物 | |
CN106456693A (zh) | 糖尿病预防或改善剂 | |
CN101505776B (zh) | 含有来自金合欢属树皮的物质的抗肥胖组合物 | |
KR20160007728A (ko) | 마늘껍질 추출물의 제조방법 및 이를 이용하여 제조된 당뇨 예방 및 개선용 식품 조성물 | |
CN107530315A (zh) | 肌肉细胞中的能量代谢激活剂 | |
JP5002127B2 (ja) | アカシア属樹皮由来物を含有する血糖降下組成物 | |
EP2260855A1 (en) | Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same | |
CN101505778B (zh) | 含有来自金合欢属树皮的物质的降血糖组合物 | |
CN101505774B (zh) | 含有来自金合欢属树皮的物质的搔痒预防和/或治疗用组合物 | |
KR101060468B1 (ko) | 유색감자를 포함하는 혈당 강하용 제제 | |
CN103920140A (zh) | 一种人用降糖减肥降脂复方制剂 | |
Metawea et al. | Study of the potential impact of Atriplex halimus L.(Chenopodiaceae) on experimental animals infected with hyperglycemia | |
Okon et al. | Nutraceutical potentials of wild and neglected edible leafy vegetables (Sterculia tragacantha and Sesamum indicum) in Akwa Ibom State-Nigeria | |
CN104013696B (zh) | 一种防治代谢综合征的植物药组合物及其应用 | |
CN103720808B (zh) | 一种具有通便功效的组合物及其用途、制备方法 | |
Eliakim-Ikechukwu et al. | Phytochemical composition of Cassia alata leaf extract and its effect on the histology of the pancreas of diabetic wistar rats | |
KR101508561B1 (ko) | 귀리를 포함하는 혼합 생약재 추출물을 함유하는 당뇨병의 예방 또는 치료용 약학조성물 | |
CN101505777B (zh) | 含有来自金合欢属树皮的物质的肿瘤的预防和/或治疗用组合物 | |
CN104000865B (zh) | 一种具有降血脂、降血糖功能的牛磺酸复合制剂 | |
Tanweer et al. | The prophylactic potential of Zingiber officinale flowers and leaves extract to mitigate hyperglycemia in Sprague Dawley rats | |
CN104082742B (zh) | 一种调理血糖平衡的功能性食品 | |
Ahmad et al. | Effect of Artemisia herb on induced hyperglycemia in wistar rats | |
CN101124990A (zh) | 葎草在制备抗疲劳、耐缺氧药物或保健食品中的新用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MIMOZAX CO., LTD. Free format text: FORMER OWNER: WOOD ONE CO LTD (JP) Effective date: 20110517 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110517 Address after: Hiroshima County, Japan Applicant after: MIMOZAX Co., Ltd. Address before: Hiroshima County, Japan Applicant before: WOODONE Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Hiroshima County, Japan Patentee after: Acacia-No-Ki Co., Ltd. Address before: Hiroshima County, Japan Patentee before: MIMOZAX Co., Ltd. |